J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M700315-JLR200 on August 22, 2007

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M700315-JLR200v1
48/11/2463    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Igarashi, M.
Right arrow Articles by Rapoport, S. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Igarashi, M.
Right arrow Articles by Rapoport, S. I.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 48, 2463-2470, November 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology

Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain

Miki Igarashi1, Kaizong Ma, Lisa Chang, Jane M. Bell and Stanley I. Rapoport

Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892

Published, JLR Papers in Press, August 22, 2007.

1 To whom correspondence should be addressed. e-mail: mikii{at}mail.nih.gov


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Fifteen weeks of dietary n-3 PUFA deprivation increases coefficients of conversion of circulating {alpha}-linolenic acid ({alpha}-LNA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) in rat liver but not brain. To determine whether these increases reflect organ differences in enzymatic activities, we examined brain and liver expression of converting enzymes and of two of their transcription factors, peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}) and sterol-regulatory element binding protein-1 (SREBP-1), in rats fed an n-3 PUFA "adequate" (4.6% {alpha}-LNA of total fatty acid, no DHA) or "deficient" (0.2% {alpha}-LNA, no DHA) diet for 15 weeks after weaning. In rats fed the deficient compared with the adequate diet, mRNA and activity levels of {Delta}5 and {Delta}6 desaturases and elongases 2 and 5 were upregulated in liver but not brain, but liver PPAR{alpha} and SREBP-1 mRNA levels were unchanged. In rats fed the adequate diet, enzyme activities generally were higher in liver than brain. Thus, differences in conversion enzyme expression explain why the liver has a greater capacity to synthesize DHA from circulating {alpha}-LNA than does the brain in animals on an adequate n-3 PUFA diet and why liver synthesis capacity is increased by dietary deprivation. These data suggest that liver n-3 PUFA metabolism determines DHA availability to the brain when DHA is absent from the diet.

Supplementary key words ß-oxidation • diet • docosahexaenoic acid • {alpha}-linolenic acid • polyunsaturated fatty acid

Abbreviations: AA, arachidonic acid (20:4n-6); CPT-1, carnitine palmitoyltransferase-1; DHA, docosahexaenoic acid (22:6n-3); DPA, docosapentaenoic acid (22:5n-6); DTA, docosatetraenoic acid (22:4n-6); EPA, eicosapentaenoic acid (20:5n-3); FAME, fatty acid methyl ester; KPB, potassium phosphate buffer; LA, linoleic acid (18:2n-6); {alpha}-LNA, {alpha}-linolenic acid (18:3n-3); PPAR, peroxisome proliferator-activated receptor; PUFA, polyunsaturated fatty acid; SREBP, sterol-regulatory element binding protein


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Adequate concentrations of docosahexaenoic acid (DHA; 22:6n-3) and arachidonic acid (AA; 20:4n-6) in brain are required to maintain normal brain function and structure. These long-chain PUFAs regulate multiple processes, including membrane fluidity, cell signaling, and gene transcription, and they and their metabolites can influence neuropathological events (1–4). The PUFAs must be obtained directly through the diet or be converted from their respective shorter chain dietary precursors, linoleic acid (LA; 18:2n-6) or {alpha}-linolenic acid ({alpha}-LNA; 18:3n-3) (5–7), as they and their precursors cannot be synthesized de novo in vertebrate tissue.

We have quantified rates of conversion of circulating {alpha}-LNA to DHA in brain and liver of unanesthetized rats that had been fed, for 15 weeks starting at 21 days of age (after weaning), an n-3 PUFA "adequate" diet (4.6% {alpha}-LNA of total fatty acid, no DHA) or an n-3 PUFA "deficient" diet (0.2% {alpha}-LNA of total fatty acid, no DHA) (8–11). Rats on the adequate diet had {alpha}-LNA to DHA conversion coefficients 39-fold higher in the liver than brain, whereas placing rats on the deficient diet increased their liver conversion coefficients by an additional 7-fold without changing their brain coefficients.

We thought it of interest to determine whether differences in conversion capacities of liver and brain under the different dietary conditions were related to differences in the organ expression of enzymes that regulate conversion. Figure 1 illustrates that conversion is catalyzed by a number of desaturases and elongases and by acyl-CoA oxidase (6, 7, 12, 13). These enzymes are expressed in many tissues but particularly in liver and brain (12, 14–16). High concentrations of DHA or {alpha}-LNA suppress the expression of liver desaturases and elongases and reduce DHA conversion from {alpha}-LNA in rat astrocytes (6, 12–15, 17).


Figure 1
View larger version (16K):
[in this window]
[in a new window]

  		Fig. 1. Pathways of n-3 and n-6 PUFA metabolism. AA, arachidonic acid; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; DTA, docosatetraenoic acid; EPA, eicosapentaenoic acid; LA, linoleic acid; {alpha}-LNA, {alpha}-linolenic acid.

 
Transcription of many of the enzymes shown in Fig. 1 may be regulated by sterol-regulatory element binding protein-1 (SREBP-1) or peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}) (12, 13, 18, 19). SREBP-1a and -1c are derived from a single gene through the involvement of different transcription start sites (20, 21). SREBP-1 is implicated in lipogenesis, and SREBP-1c is predominantly expressed in rat liver (20, 21). Liver SREBP-1 expression is reduced in rats and mice on a high dietary intake of fish oil containing DHA and eicosapentaenoic acid (EPA; 20:5n-3) (22–24), whereas n-3 PUFAs and their metabolites are ligands of PPAR{alpha} (25, 26).

In this study, we tested the hypothesis that the reported effects of the 15 week n-3 PUFA deficient compared with adequate diet (see above) on measured conversion coefficients of circulating {alpha}-LNA to DHA in brain and liver (see above) would correlate with differences in expression of the relevant conversion enzymes and of their transcription factors (10, 11). Therefore, we measured activities and/or mRNA levels of these enzymes, and of SREBP-1 and PPAR{alpha}, in brain and liver of rats fed an adequate or deficient diet for 15 weeks, starting at 21 days of age. We also examined mRNA levels of carnitine palmitoyltransferase-1 (CPT-1), which is a rate-limiting enzyme for mitochondrial ß-oxidation (27, 28).


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Materials
[1-14C]LA (51 mCi/mmol) was purchased from Perkin-Elmer Life Sciences, NEN Life Science Products (Boston, MA). [1-14C]8,11,14-eicosatrienoic acid (52 mCi/mmol) and [2-14C]malonyl-CoA (53 mCi/mmol) were obtained from Morvek (Brea, CA). Fatty acids and malonyl-CoA were purchased from Sigma-Aldrich (St. Louis, MO). Standards for general fatty acid methyl esters (FAMEs) for GC and HPLC were from NuChek Prep (Elysian, MN). Unique n-3 PUFAs (18:3n-6; 18:4n-3; 22:4n-6; and 22:5n-3) were purchased from Larodan Fine Chemicals (Malmö, Sweden). Liquid scintillation cocktail (Ready SafeTM) was purchased from Beckman Coulter (Fullerton, CA). Solvents were HPLC grade and were purchased from Fisher Scientific (Fair Lawn, NJ) or EMD Chemicals (Gibbstown, NJ). Other chemicals and reagents, unless noted otherwise, were purchased from Sigma-Aldrich or Fisher Scientific (Pittsburgh, PA).

Animals
The protocol was approved by the Animal Care and Use Committee of the National Institute of Child Health and Human Development and conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals (Publication No. 80-23). Male Fischer-344 (CDF) rat pups (18 days old) and their surrogate mothers were purchased from Charles River Laboratories (Portage, MI) and were housed in an animal facility having regulated temperature and humidity and a 12 h light/12 h dark cycle. The pups were allowed to nurse until 21 days of age. Lactating dams had free access to water and rodent chow formulation NIH-31 18-4, whose composition has been reported (29, 30).

Diets
After weaning, the pups were divided randomly into groups fed an n-3 PUFA adequate or deficient diet, with free access to food and water. Their food was replaced every 2 or 3 days, and their body weight was recorded every 2 or 3 days.

Table 1 presents the fatty acid composition of the n-3 PUFA adequate and deficient diets (10, 11, 31–33). Each was prepared by Dyets, Inc. (Bethlehem, PA), and was based on the AIN-93G formulation. Each diet contained 10% fat, and the adequate but not the deficient diet contained flaxseed oil. The adequate diet contained 7.8 µmol/g {alpha}-LNA (4.6% of total fatty acid), considered a minimum n-3 PUFA level for maintaining brain integrity in rodents (8, 9). The deficient diet contained 0.25 µmol/g {alpha}-LNA (0.2% of total fatty acid). There was no other n-3 PUFA in either diet. Both also contained 40 µmol/g LA (23–24% of total fatty acid), 110 µmol/g saturated fatty acid (65–69% of total), and 10 µmol/g monounsaturated fatty acid (5–6% of total). The rats were fed a diet for 15 weeks, starting when they were 21 days old.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Fatty acid compositions of n-3 PUFA adequate and deficient diets

 
We have reported the lipid composition of liver and brain in rats fed the n-3 PUFA adequate and deficient diets (10, 11, 32). The deficient diet reduces the liver DHA concentration by 97% and the brain DHA concentration by 30%.

Enzymes
After 15 weeks on a given diet, a rat was anesthetized by CO2 inhalation and decapitated. Its liver and brain were removed rapidly, frozen in 2-methylbutane with dry ice at –50°C, and stored at –80°C until analyzed. We then determined mRNA and/or activity levels of elongases 2, 5, and 6; {Delta}5, {Delta}6 (EC 1.14.19.3) and {Delta}9 (EC 1.14.19.1) desaturases; acyl-CoA oxidase (EC 1.3.3.6); CPT-1 (EC 2.3.1.21); and PPAR{alpha} and SREBP-1.

Total RNA isolation and real-time RT-PCR
Total RNA was isolated from liver and brain using commercial kits (RNeasy Lipid Tissue Kit; Qiagen, Valencia, CA). cDNA was prepared from total RNA using a high-capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA). mRNA levels of {Delta}5 desaturase (NM_053445), {Delta}6 desaturase (NM_031344), {Delta}9 desaturase (NM_139192), elongase 2 (AB071986), elongase 5 (NM_134382), elongase 6 (NM_134383), acyl-CoA oxidase (NM_017340), PPAR{alpha} (NM_013196), SREBP-1 (XM_213329), CPT-1a (NM_031559), and CPT-1b (NM_013200) were measured with real-time quantitative RT-PCR using an ABI PRISM 7000 sequence detection system (Applied Biosystems). Specific primers and probes [TaqMan(r) MGB probe], and TaqMan(r) Universal PCR master Mix were purchased from Applied Biosystems and consisted of a 20x mix of unlabeled PCR primers and TaqMan minor groove binder probe (FAMTM dye-labeled). Data were analyzed with comparative cycle threshold (34). Data were expressed as the level of the target gene in animals fed the deficient diet normalized to the endogenous control (ß-globulin) and relative to the level in animals fed the adequate diet.

Enzyme activities
Tissues were homogenized in 7 volumes of homogenizing buffer (10 mM Tris-HCl, pH 7.4, containing 0.25 M sucrose, 1 mM EDTA, 5 mM MgCl2, and 1 mM DTT) and centrifuged at 500 g for 10 min. A small aliquot of supernatant was kept at 80°C to measure acyl-CoA oxidase activity. The remaining supernatant was centrifuged at 10,000 g for 30 min, and the resulting supernatant then was centrifuged at 105,000 g for 60 min. The pellet was suspended in homogenizing buffer and kept at –80°C until analyzed for desaturase and elongase activities. Protein concentrations were determined using the Bradford reagent (Sigma-Aldrich).

{Delta}5 and {Delta}6 desaturase activities were analyzed by the method of Kawashima, Musoh, and Kozuka (35) with slight modifications. [1-14C]LA was used as the substrate for analysis of {Delta}6 desaturase activity, and {gamma}-linolenic acid (18:3n-6) was detected as a product. To measure {Delta}5 desaturase activity, [1-14C]8,11,14-eicosatrienoic acid (20:3n-6) was used, and AA was detected as a product. Each substrate was dissolved in 0.15% NaCl solution containing 10% BSA (described below). We did not determine the activities of {Delta}9 desaturase, elongase 6, or CPT-1.

To measure activities of the {Delta}5 and {Delta}6 desaturases, tissue microsomes (~1 mg of protein) were incubated with 100 µM fatty acid (~2.0 µCi/µmol), 2 mM NADH, 200 µM CoA, 5 mM ATP, and 5 mM MgCl2 in 1 ml of 100 mM potassium phosphate buffer (KPB), pH 7.4. After preincubation for 1 min, the reaction was started by adding microsomes and continued for 5 min. The reaction was stopped by adding 2 ml of 10% KOH in 90% methanol, then saponifying for 1 h at 100°C. The solution was acidified with 1 ml of 12 N HCl, 1 ml of water was added, and then fatty acids were extracted two times with n-hexane. The hexane phase was dried with N2 gas and methylated with 1% H2SO4 for 3 h at 70°C (32, 36). FAMEs were separated using reverse-phase HPLC as described below, peaks of substrate and product were corrected, and their radioactivities were counted using a liquid scintillation analyzer (2200CA, TRI-CARB®; Packard Instruments, Meriden, CT) with liquid scintillation cocktail (Ready SafeTM plus 1% glacial acetic acid) (37, 38). Activity was expressed as the synthesis rate of 18:3n-6 from LA for {Delta}6 desaturase and of AA from 20:3n-6 for {Delta}5 desaturase.

The elongation reactions were carried out as described by Moon et al. (39) with modifications. Microsomes (~0.2 mg of protein) were incubated in 0.2 ml of 50 mM KPB, pH 6.5, containing 5 µM rotenone, 20 µM fatty acid (bound with BSA; described below), 100 µM CoA, 1 mM ATP, 1 mM MgCl2, 1 mM NADPH, and 150 µM [2-14C]malonyl-CoA (~0.7 µCi/µmol). After preincubation for 1 min, the reaction was started by adding the microsomal fraction and then continued for 5 min. The reaction was stopped by adding 10% KOH in 90% methanol, and the solution was saponified. Fatty acids were extracted with n-hexane as described above, and radioactivity in the pooled hexane phase was counted. Enzyme activity was expressed as the rate of incorporation of malonyl-CoA into fatty acid. The fatty acids 18:3n-6, 20:4n-6, 22:4n-6, 18:4n-3, 20:5n-3, and docosapentaenoic acid (DPA; 22:5n-3) were used as substrates.

A 10 mM stock solution of each fatty acid was prepared according to the method of Hannah et al. (40) for enzyme activity analysis. Briefly, sodium salts of the fatty acid, produced by adding NaOH, were dissolved in 0.15 M NaCl containing 10% (w/v) BSA (fatty acid-free), and the solution was sonicated for 20 min at room temperature. Aliquots of the solution were kept at –80°C in a tube under nitrogen gas that was protected from light.

Acyl-CoA oxidase activity was measured using the method of Ide et al. (28, 41). The 500 g supernatant fraction was used for analysis, and palmitoyl-CoA was used as a substrate. The enzyme solution was incubated with 10 mM phenol, 0.82 mM 4-aminoantipyrine, 10 mM flavin adenine dinucleotide, 4 units of horseradish peroxidase, 0.05 mM palmitoyl-CoA, and 0.2 mg of BSA in 1 ml of 50 mM KPB, pH 7.4. After preincubation for 1 min at 30°C, the reaction was started by adding palmitoyl-CoA, and absorbance at 500 nm was monitored. An absorbance coefficient of quinoneimine dye to 6,390 M–1 cm–1 was used for calculations.

HPLC analysis
HPLC was used to determine desaturase activities. The FAMEs were dissolved in acetonitrile, and the solution was fractionated by reverse-phase column HPLC using a pump (System GOLD 126; Beckman Coulter) outfitted with an untraviolet light detector (UV/VIS-151; Gilson, Middleton, WI). The reverse-phase column, Luna 5 µC18 (2) (5 µM particle size, 4.6 x 250 mm), was purchased from Phenomenex (Torrance, CA). Chromatography was performed using a linear gradient system of water and acetonitrile at a flow rate of 1.0 ml/min with the detector set at 205 nm. The acetonitrile was held at 85% for 30 min, increased to 100% over 10 min, and held again at 100% for 20 min.

Statistical analysis
Data are expressed as means ± SD. An unpaired Student's t-test was used to compare means in two groups. Tukey's test was used for multiple comparisons. Statistical significance was taken at P < 0.05.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Activity and mRNA expression of desaturases in liver and brain
mRNA levels and activities of desaturases were determined in liver and brain from rats fed an n-3 PUFA adequate or deficient diet. As shown in Fig. 2 , {Delta}6 and {Delta}5 desaturase activities were higher in the liver than in the brain of rats on the adequate diet. The activities of these desaturases were increased by 2-fold in the liver of rats fed the deficient compared with the adequate diet, but they were not changed significantly in the brain. In the liver of rats fed the deficient diet, furthermore, the mRNA levels of the {Delta}6 and {Delta}5 desaturases were increased by 2-fold and 1.3-fold, respectively (Table 2 ). No effect of dietary deprivation was noted in the brain.


Figure 2
View larger version (11K):
[in this window]
[in a new window]

  		Fig. 2. Activities of {Delta}5 and {Delta}6 desaturases in liver (A) and brain (B) of rats fed an n-3 PUFA adequate or deficient diet. Values are means ± SD (n = 10 for each group). * P < 0.05 compared with the mean in the adequate group.

 

View this table:
[in this window]
[in a new window]

  		TABLE 2. mRNA expression of different desaturases, elongases, and oxidation enzymes, as well as of transcription factors, in liver and brain of rats fed an n-3 PUFA adequate or deficient diet

 
{Delta}9 desaturase can catalyze the synthesis of monounsaturated fatty acids, and transcription of its gene is controlled by PPAR{alpha} and SREBP-1 (42). However, its liver mRNA level was unaffected by the deficient diet (Table 2); therefore, its activity was not measured.

Activity and mRNA expression of elongases in liver and brain
mRNA and activity levels of elongases were analyzed in liver and brain of rats fed the n-3 PUFA adequate or deficient diet (Fig. 3 ). Elongase 2 can use C20–C22 PUFAs as substrates, whereas elongase 5 can act on a broad array of C16–C20 PUFAs (19, 43). We analyzed elongase activities using 18:3n-6, 20:4n-6 (AA), 22:4n-6 [docosatetraenoic acid(DTA)], 18:4n-3, 20:5n-3 (EPA), and 22:5n-3 (DPA n-3) as substrates. In the liver of the n-3 PUFA-deprived rats, elongation activity was increased when the substrate was 20:4n-6, 20:5n-3, or 22:4n-6, consistent with increased elongase 2 and 5 activities. 20:4n-6 and 22:4n-6 were elongated 1.5 and 2 times faster in the liver of the adequate diet rats than were 20:5n-3 and 22:5n-3, respectively.


Figure 3
View larger version (19K):
[in this window]
[in a new window]

  		Fig. 3. Elongation activity in the liver (A) and brain (B) of rats fed an n-3 PUFA adequate or deficient diet. Values are means ± SD (n = 10 for both groups). * P < 0.05 compared with the mean in the adequate group; {dagger} P < 0.05 compared with elongation activity with AA in the adequate group; {dagger}{dagger}{dagger} P < 0.001 compared with elongation activity with docosatetraenoic acid (DTA) in the adequate group.

 
In rats fed the adequate diet, brain elongase activities were one-fifth to one-tenth their respective activities in liver. In brain, 22:4n-6 was elongated 2.5 times faster than was 22:5n-3. In rats fed the deprived compared with the adequate diet, mRNA levels of liver elongases 2 and 5 were increased 1.5-fold and 1.4-fold, respectively (Table 2), whereas deprivation did not affect the mRNA level of either enzyme in brain. The liver mRNA level of elongase 6, which we also measured, was unaffected by the n-3 PUFA deficient diet, and we did not determine the activity of this enzyme.

Activity and mRNA expression of acyl-CoA oxidase in rat liver and brain
As illustrated in Fig. 4 and Table 2, n-3 PUFA deprivation did not change the mRNA or activity level of acyl-CoA oxidase in either liver or brain. The activity of this enzyme in liver was six times higher than that in brain in rats fed the adequate diet.


Figure 4
View larger version (10K):
[in this window]
[in a new window]

  		Fig. 4. Acyl-CoA oxidase activity in liver and brain of rats fed an n-3 PUFA adequate or deficient diet. Values are means ± SD (n = 10 for both groups).

 
Effects of the deficient diet on the expression of CPT-1
mRNA levels of CPT-1a and/or CPT-1b were determined in rat liver and brain to see if dietary deprivation affected this marker of mitochondrial ß-oxidation. The deficient diet did not change the mRNA level of CPT-1a in liver but did significantly reduce levels of CPT-1a and CPT-1b in brain (Table 2).

Effects of diet on the expression of PPAR{alpha} and SREBP-1 in rat liver
Although several studies have shown that SREBP-1 and PPAR{alpha} can regulate the transcription of elongases, desaturases, and acyl-CoA oxidase for PUFAs (12, 13, 18, 19), there was no significant difference in the mRNA levels of PPAR{alpha} or SREBP-1 between rats fed the deficient or adequate diet (Table 2).


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
In rats on the n-3 PUFA adequate diet, baseline activities of the enzymes involved in converting LA to AA and {alpha}-LNA to DHA (Fig. 1) were generally higher in liver than in brain. Additionally, mRNA and/or activity levels of elongases 2 and 5 but not of elongase 6, and of {Delta}5 and {Delta}6 desaturases but not of {Delta}9 desaturase, were upregulated in liver but not brain in rats fed the n-3 PUFA deficient compared with adequate diet for 15 weeks. Acyl-CoA oxidase activity in both organs was unaffected by dietary deprivation. The mRNA level of CPT-1a in the liver was unchanged, whereas mRNA levels of CPT-1a and CPT-1b were reduced in brain by deprivation. The mRNA levels of the transcription factors SREBP-1 and PPAR{alpha} in liver also were unaffected by the n-3 PUFA deficient diet.

These differences with regard to enzyme expression correspond to kinetic differences that were measured after intravenous infusion of [1-14C]{alpha}-LNA into unanesthetized rats that had been fed each of the two diet regimens for 15 weeks (10, 11, 37, 44). In those studies, baseline coefficients of the conversion of circulating {alpha}-LNA to DHA were higher in liver than in brain in rats on the n-3 PUFA adequate diet, consistent with higher converting enzyme activities in the liver in rats on this diet (Figs. 1–3) (10, 11). Furthermore, placing rats on the deficient diet increased conversion coefficients by 10-fold in liver but did not change them in brain (10, 11, 37, 44), consistent with the upregulation of enzyme activities in liver but not in brain in rats on the deficient diet.

Desaturases and elongase 5 are expressed in many rodent tissues, but their expression is highest in liver and brain (12, 14, 15, 45, 46). Elongase 2 mRNA has been detected in liver, brain, lung, kidney, and white adipose tissue, with the liver having the highest expression, followed by the brain (12, 45). We determined enzyme activities only in the liver and brain in this study, to test the hypothesis that differences in activities would correspond to reported differences in conversion coefficients of {alpha}-LNA to DHA in the two organs under the different dietary conditions (10, 11, 29). Within brain, DHA biosynthesis occurs mainly in astrocytes (17, 47).

Dietary n-3 PUFA deprivation upregulated liver mRNA levels of {Delta}5 and {Delta}6 desaturases and elongases 2 and 5 without changing mRNA levels of elongase 6, {Delta}9 desaturase, or acyl-CoA oxidase (Table 2). Transcription of the affected liver enzymes can be controlled by PPAR{alpha} and SREBP-1 (12, 18, 46), but because the liver mRNA levels of PPAR{alpha} and SREBP-1 were unchanged by dietary deprivation, it is possible that their posttranslational regulation was altered (48–50). We did not examine this possibility. Expression of other transcription factors may have been changed, but we did not examine this either. These factors include liver X nuclear receptor, carbohydrate-regulatory element binding protein, MAX-like factor X, retinoid X receptor, hepatic nuclear factor-4, and thyroid hormone receptor (18, 51, 52).

The half-life of DHA in brain is prolonged by 3-fold in rats fed the deficient compared with adequate diet (32). This prolongation has been ascribed to downregulated expression of DHA-metabolizing enzymes, namely Ca2+-independent phospholipase A2 (iPLA2) and cyclooxygenase-1 (47, 53, 54). Our current results suggest that reduced brain expression of CPT-1a and CPT-1b also might contribute to the prolonged DHA half-life. These enzymes promote the entry into mitochondria of DHA and {alpha}-LNA from the brain acyl-CoA pool for subsequent ß-oxidation (55, 56).

Others also have reported that the dietary PUFA composition affects desaturase and elongase activities in rat liver. In one study, feeding fish oil decreased liver elongase and desaturase activities (12, 57, 58), whereas in another study, a corn oil diet rich in LA suppressed liver {Delta}6 desaturase activity (14). A diet deficient in both LA and {alpha}-LNA increased desaturase and elongase activities in rat liver (59, 60), and we show here that a dietary n-3 PUFA deficiency alone increased liver desaturase and elongase activities. In one study, however, feeding a diet like ours, deficient in {alpha}-LNA, to rats for 2 and 6 months did not affect liver {Delta}6 desaturase activity (61).

It is well recognized that dietary n-3 PUFA deprivation leads to DPAn-6 accumulation in rat brain, liver, plasma, and heart (9–11, 62–68). DPAn-6 synthesis from AA can be catalyzed by elongases 2 and 5, {Delta}6 desaturase, and acyl-CoA oxidase (Fig. 1), and it has been suggested that DPA n-6 accumulates in the deprived brain because some of these enzymes are disinhibited by the reduced concentration of DHA (2, 69). On the other hand, a high DPAn-6 concentration in plasma of rats on the n-3 PUFA deficient diet could increase brain DPAn-6 (32).

In summary, 15 weeks of dietary n-3 PUFA deprivation starting at 21 days of age upregulated the expression and activity of {Delta}5 and {Delta}6 desaturases and of elongases 2 and 5 in rat liver but not brain, did not affect the expression of acyl-CoA oxidase in either organ, and downregulated the expression of CPT-1a and CPT-1b in brain. These changes likely explain why such deprivation increases coefficients of DHA synthesis from circulating unesterified {alpha}-LNA in liver but not brain (10, 11). Furthermore, lower enzyme activities in brain than liver of rats fed the adequate diet correspond to reported lower conversion coefficients in brain (10, 11, 29, 37).

In rats fed the adequate diet for 15 weeks, the estimated rate of DHA synthesis by the brain from circulating {alpha}-LNA is ~1% of the brain's DHA consumption rate (70, 71). In contrast, the estimated rate of secretion by the liver of the DHA that it has synthesized from {alpha}-LNA is 10-fold the brain's DHA consumption rate, more than sufficient to supply the brain's DHA requirements. This high synthesis-secretion rate is supported by the high expression of conversion enzymes in the liver.

Our kinetic and enzyme data show that the liver can maintain brain DHA composition when DHA is absent from the diet but a sufficient amount (4.6% of total fatty acid) of {alpha}-LNA is present and when dietary {alpha}-LNA is reduced to some extent (which has yet to be determined). This ability is attributable to high baseline liver converting enzyme activities and to increases in these activities in response to n-3 PUFA deprivation. This conclusion implies that conditions such as liver disease, diabetes, and aging, in which liver conversion enzymes can be downregulated (72–74), are risk factors for brain diseases involving disturbed PUFA metabolism.


   ACKNOWLEDGMENTS
 
This research was supported entirely by the intramural program of the National Institute on Aging, National Institutes of Health. The authors thank the National Institutes of Health Fellows Editorial Board for editorial assistance.

Manuscript received July 11, 2007 and in revised form August 17, 2007.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
  1. Innis, S. M. 2000. The role of dietary n-6 and n-3 fatty acids in the developing brain. Dev. Neurosci. 22: 474–480.[CrossRef][Medline]

  2. Uauy, R., P. Mena, and C. Rojas. 2000. Essential fatty acids in early life: structural and functional role. Proc. Nutr. Soc. 59: 3–15.[Medline]

  3. Salem, N., Jr., B. Litman, H. Y. Kim, and K. Gawrisch. 2001. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids. 36: 945–959.[Medline]

  4. Youdim, K. A., A. Martin, and J. A. Joseph. 2000. Essential fatty acids and the brain: possible health implications. Int. J. Dev. Neurosci. 18: 383–399.[CrossRef][Medline]

  5. Sauerwald, T. U., D. L. Hachey, C. L. Jensen, H. Chen, R. E. Anderson, and W. C. Heird. 1997. Intermediates in endogenous synthesis of C22:6 omega 3 and C20:4 omega 6 by term and preterm infants. Pediatr. Res. 41: 183–187.[Medline]

  6. Sprecher, H. 2000. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. Biophys. Acta. 1486: 219–231.[Medline]

  7. Jump, D. B., D. Botolin, Y. Wang, J. Xu, B. Christian, and O. Demeure. 2005. Fatty acid regulation of hepatic gene transcription. J. Nutr. 135: 2503–2506.[Abstract/Free Full Text]

  8. Bourre, J. M., G. Durand, G. Pascal, and A. Youyou. 1989. Brain cell and tissue recovery in rats made deficient in n-3 fatty acids by alteration of dietary fat. J. Nutr. 119: 15–22.[Abstract/Free Full Text]

  9. Bourre, J. M., M. Francois, A. Youyou, O. Dumont, M. Piciotti, G. Pascal, and G. Durand. 1989. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 119: 1880–1892.[Abstract/Free Full Text]

  10. Igarashi, M., J. C. Demar, Jr., K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport. 2007. Upregulated liver conversion of {alpha}-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet. J. Lipid Res. 48: 152–164.[Abstract/Free Full Text]

  11. Igarashi, M., J. C. Demar, Jr., K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport. 2007. Rate of synthesis of docosahexaenoic acid from {alpha}-linolenic acid by rat brain is not altered by dietary n-3 polyunsaturated fatty acid deprivation. J. Lipid Res. 48: 1150–1158.[Abstract/Free Full Text]

  12. Wang, Y., D. Botolin, B. Christian, J. Busik, J. Xu, and D. B. Jump. 2005. Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. J. Lipid Res. 46: 706–715.[Abstract/Free Full Text]

  13. Nakamura, M. T., and T. Y. Nara. 2003. Essential fatty acid synthesis and its regulation in mammals. Prostaglandins Leukot. Essent. Fatty Acids. 68: 145–150.[CrossRef][Medline]

  14. Cho, H. P., M. T. Nakamura, and S. D. Clarke. 1999. Cloning, expression, and nutritional regulation of the mammalian Delta-6 desaturase. J. Biol. Chem. 274: 471–477.[Abstract/Free Full Text]

  15. Cho, H. P., M. Nakamura, and S. D. Clarke. 1999. Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J. Biol. Chem. 274: 37335–37339.[Abstract/Free Full Text]

  16. Van Veldhoven, P., and G. P. Mannaerts. 1985. Comparison of the activities of some peroxisomal and extraperoxisomal lipid-metabolizing enzymes in liver and extrahepatic tissues of the rat. Biochem. J. 227: 737–741.[Medline]

  17. Williard, D. E., S. D. Harmon, T. L. Kaduce, M. Preuss, S. A. Moore, M. E. Robbins, and A. A. Spector. 2001. Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. J. Lipid Res. 42: 1368–1376.[Abstract/Free Full Text]

  18. Wang, Y., D. Botolin, J. Xu, B. Christian, E. Mitchell, B. Jayaprakasam, M. G. Nair, J. M. Peters, J. V. Busik, L. K. Olson, et al. 2006. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J. Lipid Res. 47: 2028–2041.[Abstract/Free Full Text]

  19. Jakobsson, A., R. Westerberg, and A. Jacobsson. 2006. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog. Lipid Res. 45: 237–249.[CrossRef][Medline]

  20. Shimano, H. 2000. Sterol regulatory element-binding protein-1 as a dominant transcription factor for gene regulation of lipogenic enzymes in the liver. Trends Cardiovasc. Med. 10: 275–278.[CrossRef][Medline]

  21. Shimano, H. 2001. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog. Lipid Res. 40: 439–452.[CrossRef][Medline]

  22. Xu, J., M. T. Nakamura, H. P. Cho, and S. D. Clarke. 1999. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J. Biol. Chem. 274: 23577–23583.[Abstract/Free Full Text]

  23. Nakatani, T., H. J. Kim, Y. Kaburagi, K. Yasuda, and O. Ezaki. 2003. A low fish oil inhibits SREBP-1 proteolytic cascade, while a high-fish-oil feeding decreases SREBP-1 mRNA in mice liver: relationship to anti-obesity. J. Lipid Res. 44: 369–379.[Abstract/Free Full Text]

  24. Takahashi, M., N. Tsuboyama-Kasaoka, T. Nakatani, M. Ishii, S. Tsutsumi, H. Aburatani, and O. Ezaki. 2002. Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production. Am. J. Physiol. Gastrointest. Liver Physiol. 282: G338–G348.[Abstract/Free Full Text]

  25. Forman, B. M., J. Chen, and R. M. Evans. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA. 94: 4312–4317.[Abstract/Free Full Text]

  26. Krey, G., O. Braissant, F. L'Horset, E. Kalkhoven, M. Perroud, M. G. Parker, and W. Wahli. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11: 779–791.[Abstract/Free Full Text]

  27. Bonnefont, J. P., F. Djouadi, C. Prip-Buus, S. Gobin, A. Munnich, and J. Bastin. 2004. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol. Aspects Med. 25: 495–520.[CrossRef][Medline]

  28. Ide, T., H. Kobayashi, L. Ashakumary, I. A. Rouyer, Y. Takahashi, T. Aoyama, T. Hashimoto, and M. Mizugaki. 2000. Comparative effects of perilla and fish oils on the activity and gene expression of fatty acid oxidation enzymes in rat liver. Biochim. Biophys. Acta. 1485: 23–35.[Medline]

  29. DeMar, J. C., Jr., K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport. 2005. {alpha}-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 94: 1063–1076.[CrossRef][Medline]

  30. DeMar, J. C., Jr., H. J. Lee, K. Ma, L. Chang, J. M. Bell, S. I. Rapoport, and R. P. Bazinet. 2006. Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim. Biophys. Acta. 1761: 1050–1059.[Medline]

  31. DeMar, J. C., Jr., K. Ma, J. M. Bell, M. Igarashi, D. Greenstein, and S. I. Rapoport. 2006. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J. Lipid Res. 47: 172–180.[Abstract/Free Full Text]

  32. DeMar, J. C., Jr., K. Ma, J. M. Bell, and S. I. Rapoport. 2004. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 91: 1125–1137.[CrossRef][Medline]

  33. Reeves, P. G., F. H. Nielsen, and G. C. Fahey, Jr. 1993. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123: 1939–1951.[Abstract/Free Full Text]

  34. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25: 402–408.[CrossRef][Medline]

  35. Kawashima, Y., K. Musoh, and H. Kozuka. 1990. Peroxisome proliferators enhance linoleic acid metabolism in rat liver. Increased biosynthesis of omega 6 polyunsaturated fatty acids. J. Biol. Chem. 265: 9170–9175.[Abstract/Free Full Text]

  36. Makrides, M., M. A. Neumann, R. W. Byard, K. Simmer, and R. A. Gibson. 1994. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr. 60: 189–194.[Abstract/Free Full Text]

  37. Igarashi, M., K. Ma, L. Chang, J. M. Bell, S. I. Rapoport, and J. C. DeMar, Jr. 2006. Low liver conversion rate of alpha-linolenic to docosahexaenoic acid in awake rats on a high-docosahexaenoate-containing diet. J. Lipid Res. 47: 1812–1822.[Abstract/Free Full Text]

  38. Aveldano, M. I., M. VanRollins, and L. A. Horrocks. 1983. Separation and quantitation of free fatty acids and fatty acid methyl esters by reverse phase high pressure liquid chromatography. J. Lipid Res. 24: 83–93.[Abstract]

  39. Moon, Y. A., N. A. Shah, S. Mohapatra, J. A. Warrington, and J. D. Horton. 2001. Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J. Biol. Chem. 276: 45358–45366.[Abstract/Free Full Text]

  40. Hannah, V. C., J. Ou, A. Luong, J. L. Goldstein, and M. S. Brown. 2001. Unsaturated fatty acids down-regulate SREBP isoforms 1a and 1c by two mechanisms in HEK-293 cells. J. Biol. Chem. 276: 4365–4372.[Abstract/Free Full Text]

  41. Ide, T., M. Murata, and M. Sugano. 1996. Stimulation of the activities of hepatic fatty acid oxidation enzymes by dietary fat rich in alpha-linolenic acid in rats. J. Lipid Res. 37: 448–463.[Abstract]

  42. Nakamura, M. T., and T. Y. Nara. 2004. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu. Rev. Nutr. 24: 345–376.[CrossRef][Medline]

  43. Leonard, A. E., S. L. Pereira, H. Sprecher, and Y. S. Huang. 2004. Elongation of long-chain fatty acids. Prog. Lipid Res. 43: 36–54.[CrossRef][Medline]

  44. Igarashi, M., K. Ma, L. Chang, J. M. Bell, S. I. Rapoport, and J. C. DeMar, Jr. 2006. Low liver conversion rate of alpha-linolenic to docosahexaenoic acid in awake rats on a high-docosahexaenoate-containing diet. J Lipid Res. 47: 1812–1822.[Abstract/Free Full Text]

  45. Tvrdik, P., R. Westerberg, S. Silve, A. Asadi, A. Jakobsson, B. Cannon, G. Loison, and A. Jacobsson. 2000. Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids. J. Cell Biol. 149: 707–718.[Abstract/Free Full Text]

  46. Matsuzaka, T., H. Shimano, N. Yahagi, M. Amemiya-Kudo, T. Yoshikawa, A. H. Hasty, Y. Tamura, J. Osuga, H. Okazaki, Y. Iizuka, et al. 2002. Dual regulation of mouse Delta(5)- and Delta(6)-desaturase gene expression by SREBP-1 and PPARalpha. J. Lipid Res. 43: 107–114.[Abstract/Free Full Text]

  47. Strokin, M., M. Sergeeva, and G. Reiser. 2003. Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br. J. Pharmacol. 139: 1014–1022.[CrossRef][Medline]

  48. Bengoechea-Alonso, M. T., and J. Ericsson. 2007. SREBP in signal transduction: cholesterol metabolism and beyond. Curr. Opin. Cell Biol. 19: 215–222.[CrossRef][Medline]

  49. Lu, M., and J. Y. Shyy. 2006. Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation. Am. J. Physiol. 290: C1477–C1486.[CrossRef]

  50. Blanquart, C., O. Barbier, J. C. Fruchart, B. Staels, and C. Glineur. 2003. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J. Steroid Biochem. Mol. Biol. 85: 267–273.[CrossRef][Medline]

  51. Montanaro, M. A., M. S. Gonzalez, A. M. Bernasconi, and R. R. Brenner. 2007. Role of liver X receptor, insulin and peroxisome proliferator activated receptor alpha on in vivo desaturase modulation of unsaturated fatty acid biosynthesis. Lipids. 42: 197–210.[CrossRef][Medline]

  52. Duplus, E., and C. Forest. 2002. Is there a single mechanism for fatty acid regulation of gene transcription? Biochem. Pharmacol. 64: 893–901.[CrossRef][Medline]

  53. Rao, J. S., R. N. Ertley, J. C. DeMar, Jr., S. I. Rapoport, R. P. Bazinet, and H. J. Lee. 2007. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol. Psychiatry. 12: 151–157.[CrossRef][Medline]

  54. Murakami, M., T. Kambe, S. Shimbara, and I. Kudo. 1999. Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J. Biol. Chem. 274: 3103–3105.[Abstract/Free Full Text]

  55. Gavino, G. R., and V. C. Gavino. 1991. Rat liver outer mitochondrial carnitine palmitoyltransferase activity towards long-chain polyunsaturated fatty acids and their CoA esters. Lipids. 26: 266–270.[Medline]

  56. Doh, K. O., Y. W. Kim, S. Y. Park, S. K. Lee, J. S. Park, and J. Y. Kim. 2005. Interrelation between long-chain fatty acid oxidation rate and carnitine palmitoyltransferase 1 activity with different isoforms in rat tissues. Life Sci. 77: 435–443.[CrossRef][Medline]

  57. Garg, M. L., A. B. Thomson, and M. T. Clandinin. 1988. Effect of dietary cholesterol and/or omega 3 fatty acids on lipid composition and delta 5-desaturase activity of rat liver microsomes. J. Nutr. 118: 661–668.[Abstract/Free Full Text]

  58. Garg, M. L., E. Sebokova, A. B. Thomson, and M. T. Clandinin. 1988. Delta 6-desaturase activity in liver microsomes of rats fed diets enriched with cholesterol and/or omega 3 fatty acids. Biochem. J. 249: 351–356.[Medline]

  59. Peluffo, R. O., A. M. Nervi, and R. R. Brenner. 1976. Linoleic acid desaturation activity of liver microsomes of essential fatty acid deficient and sufficient rats. Biochim. Biophys. Acta. 441: 25–31.[Medline]

  60. Bernert, J. T., Jr., and H. Sprecher. 1975. Studies to determine the role rates of chain elongation and desaturation play in regulating the unsaturated fatty acid composition of rat liver lipids. Biochim. Biophys. Acta. 398: 354–363.[Medline]

  61. Dinh, T. K., J. M. Bourre, and G. Durand. 1993. Effect of age and alpha-linolenic acid deficiency on delta 6 desaturase activity and liver lipids in rats. Lipids. 28: 517–523.[CrossRef][Medline]

  62. Galli, C., H. B. White, Jr., and R. Paoletti. 1971. Lipid alterations and their reversion in the central nervous system of growing rats deficient in essential fatty acids. Lipids. 6: 378–387.[CrossRef][Medline]

  63. Anderson, R. E., R. M. Benolken, P. A. Dudley, D. J. Landis, and T. G. Wheeler. 1974. Proceedings. Polyunsaturated fatty acids of photoreceptor membranes. Exp. Eye Res. 18: 205–213.[CrossRef][Medline]

  64. Moriguchi, T., S. Y. Lim, R. Greiner, W. Lefkowitz, J. Loewke, J. Hoshiba, and N. Salem, Jr. 2004. Effects of an n-3-deficient diet on brain, retina, and liver fatty acyl composition in artificially reared rats. J. Lipid Res. 45: 1437–1445.[Abstract/Free Full Text]

  65. Greiner, R. S., J. N. Catalan, T. Moriguchi, and N. Salem, Jr. 2003. Docosapentaenoic acid does not completely replace DHA in n-3 FA-deficient rats during early development. Lipids. 38: 431–435.[Medline]

  66. Lim, S. Y., J. Hoshiba, T. Moriguchi, and N. Salem, Jr. 2005. N-3 fatty acid deficiency induced by a modified artificial rearing method leads to poorer performance in spatial learning tasks. Pediatr. Res. 58: 741–748.[CrossRef][Medline]

  67. Contreras, M. A., M. C. Chang, T. A. Rosenberger, R. S. Greiner, C. S. Myers, N. Salem, Jr., and S. I. Rapoport. 2001. Chronic nutritional deprivation of n-3 alpha-linolenic acid does not affect n-6 arachidonic acid recycling within brain phospholipids of awake rats. J. Neurochem. 79: 1090–1099.[CrossRef][Medline]

  68. Contreras, M. A., R. S. Greiner, M. C. Chang, C. S. Myers, N. Salem, Jr., and S. I. Rapoport. 2000. Nutritional deprivation of alpha-linolenic acid decreases but does not abolish turnover and availability of unacylated docosahexaenoic acid and docosahexaenoyl-CoA in rat brain. J. Neurochem. 75: 2392–2400.[CrossRef][Medline]

  69. Holman, R. T. 1986. Control of polyunsaturated acids in tissue lipids. J. Am. Coll. Nutr. 5: 183–211.[Abstract]

  70. Rapoport, S. I., J. S. Rao, and M. Igarashi. 2007. Regulation by diet and liver of brain metabolism of nutritionally essential polyunsaturated fatty acids. Mai-Aout 2007, Conference Chevreul. Oleagineux, Corps Gras, Lipides. 14: 216–223.

  71. Rapoport, S. I., J. Rao, and M. Igarashi. 2007. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Other Lipid Mediat. In press.

  72. Brenner, R. R. 2003. Hormonal modulation of delta6 and delta5 desaturases: case of diabetes. Prostaglandins Leukot. Essent. Fatty Acids. 68: 151–162.[CrossRef][Medline]

  73. Bourre, J. M., and M. Piciotti. 1992. Delta-6 desaturation of alpha-linolenic acid in brain and liver during development and aging in the mouse. Neurosci. Lett. 141: 65–68.[CrossRef][Medline]

  74. Burke, P. A., P. R. Ling, R. A. Forse, D. W. Lewis, R. Jenkins, and B. R. Bistrian. 2001. Sites of conditional essential fatty acid deficiency in end stage liver disease. JPEN J. Parenter. Enteral Nutr. 25: 188–193.[Abstract]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
M. Igarashi, K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport
Rat heart cannot synthesize docosahexaenoic acid from circulating {alpha}-linolenic acid because it lacks elongase-2
J. Lipid Res., August 1, 2008; 49(8): 1735 - 1745.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. T. Green, S. K. Orr, and R. P. Bazinet
The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids
J. Lipid Res., May 1, 2008; 49(5): 939 - 944.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. T. Chen, D. W. L. Ma, J. H. Kim, H. T. J. Mount, and R. P. Bazinet
The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations
J. Lipid Res., January 1, 2008; 49(1): 147 - 152.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M700315-JLR200v1
48/11/2463    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow